DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,415 | -20.4% | 13,216 | 0.0% | 0.04% | -12.5% |
| Q2 2023 | $148,680 | -51.2% | 13,216 | -50.0% | 0.05% | -9.4% |
| Q1 2023 | $304,496 | +97.2% | 26,432 | +98.3% | 0.05% | -3.6% |
| Q4 2022 | $154,448 | -7.5% | 13,326 | +1.2% | 0.06% | -11.3% |
| Q3 2022 | $167,000 | +83.5% | 13,168 | -0.2% | 0.06% | +87.9% |
| Q2 2022 | $91,000 | -28.3% | 13,191 | 0.0% | 0.03% | -13.2% |
| Q1 2022 | $127,000 | -15.3% | 13,191 | +4.2% | 0.04% | -9.5% |
| Q4 2021 | $150,000 | -26.1% | 12,657 | +1.2% | 0.04% | -34.4% |
| Q3 2021 | $203,000 | -22.8% | 12,513 | 0.0% | 0.06% | -16.9% |
| Q2 2021 | $263,000 | +35.6% | 12,513 | 0.0% | 0.08% | +28.3% |
| Q1 2021 | $194,000 | – | 12,513 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |